In vivo regulation of telomerase activity and telomere length

Immunological Reviews

Volumn 205, Issue , 2005, Pages 104-113

  Hathcock, Karen S ^a   Chiang, Y Jeffrey ^a   Hodes, Richard J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CELL AGING; CELL DEATH; CELL DIVISION; CELL MATURATION; CELLULAR IMMUNITY; DNA PROTEIN COMPLEX; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME INDUCTION; ENZYME REGULATION; HUMAN; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TELOMERE;

ANIMALS; CELL AGING; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 20344368293     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00267.x     Document Type: Review

References (57)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1956;37:614-636.
2. Greider CW. Telomere length regulation. Annu Rev Biochem 1996;65:337-365.
3. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000;34:331-358.
4. Greider CW, Blackburn EH. Identification of a specific terminal transferase activity in Tetrahymena extracts. Cell 1985;43: 405-413.
5. Nakamura TM, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-959.
6. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho. Expression of mouse telomerase reverse transcriptase during development, differentiation, and proliferation. Oncogene 1998;16:1723-1730.
7. Greider CW, Blackburn EH. A telomereic sequence in the RNA of tetrahymena telomerase required for telomere repeat synthesis. Nature 1989;337:331-337.
8. Feng J, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
9. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tails of tails, regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997;160:43-54.
10. Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 1998;9:151-157.
11. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol 2002;2:699-706.
12. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995;92:4818-4822.
13. Blasco MA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997;91:25-34.
14. Hathcock KS, Weng NP, Merica R, Jenkins MK, Hodes RJ. Cutting edge: antigen-dependent regulation of telomerase activity in murine T cells. J Immunol 1998;160: 5702-5706.
15. + T cells. J Immunol 2003;170:147-152.
16. Greenwood MJ, Lansdorp PM. Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res 2003;34:489-495.
17. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging in human fibroblasts. Nature 1990;345:458-460.
18. Haslie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
19. Vaziri H, et al. Loss if telomeric DNA during ageing of normal and trisomy-21 human lymphocytes. Am J Hum Genet 1993;52:661-667.
20. Aisner DL, Wright WE, Shay JW. Telomerase regulation: not just flipping the switch. Curr Opin Gen Dev 2002;12:60-65.
21. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol 2002;41:29-40.
22. Bodnar AG, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
23. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003;4:835-842.
24. Liu K, Hodes RJ, Weng N. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001;166:4826-4830.
25. Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
26. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
27. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393-395.
28. Kipling D, Cooke HJ. Hypervariable ultralong telomeres in mice. Nature 1990;347:400-402.
29. Coviello-McLaughlin GM, Prowse KR. Telomere length regulation during postnatal development and aging in Mus Spretus. Nucleic Acids Res 1997;25:3051-3057.
30. 3 repeats. Proc Natl Acad Sci USA 1997;94:7423-7428.
31. Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res 2000;28:4474-4478.
32. Broccoli D, Godley LA, Donehower LA, Varmus HE, de Lange T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 1996;16:3765-3772.
33. Gonzalez-Suarez E, et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001;20:2619-2630.
34. Artandi SE, et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 2002;99:8191-8196.
35. Canela A, Martin-Caballero J, Flores JM, Blasco MA. Constituative expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 2004;24:4275-4293.
36. Chiang YJ, et al. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere maintenance in vivo. Mol Cell Biol 2004;24: 7024-7031.
37. Lee H-W, Blasco MA, Gottlieb GJ, Horner JWII, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998;392:569-574.
38. Herra E, Martinez AC, Blasco MA. Impaired germinal center reaction in mice with short telomeres. EMBO J 2000;19:472-481.
39. Herra E, Samper E, Martin-Caballo J, Flores JM, Lee H-W, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1990;18:2950-2960.
40. Rudolph KL, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999;96:701-712.
41. Blasco MA. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett 2003;194:183-188.
42. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-329.
43. Pape KA, et al. Use of adoptive transfer of T-cell-antigen-receptor- transgenic T cells for the study of T-cell activation in vivo. Immunol Rev 1997;156:67-78.
44. Buchmeier MJ, Zajac AJ. Lymphocytic choriomeningitis virus. In: Ahmed R, Chen ISY, eds. Persistent Viral Infections. Chichester: John Wiley & Sons, 1999:575-605.
45. Murali-Kirshna K, Lau LL, Sambhara S, Lemonnier F, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999;286:1377-1381.
46. Matsuda Y, Hirobe T, Chapman VM. Genetic basis of X-Y chromosome dissociation and male sterility in interspecific hybrids. Proc Natl Acad Sci USA 1991;88:4850-4854.
47. Zhu L, Hathcock KS, Hande P, Lansdorp PM, Seldin MF, Hodes RJ. Telomere length regulation in mice is linked to a novel chromosome locus. Proc Nat Acad Sci USA 1998;95:8648-8653.
48. Ding H, et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 2004;171: 873-886.
49. Hathcock KS, Hemann MT, Opperman KK, Strong MA, Greider CW, Hodes RJ. Haploinsufficiency of mTR results in defects in telomere elongation. Proc Natl Acad Sci USA 2002;99:3591-3596.
50. Erdmann N, Liu Y, Harrington L. Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci USA 2002;101:6080-6085.
51. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001;107:67-77.
52. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenital. Nature 1999;402:551-555.
53. Vulliamy T, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenital. Nature 2001;413:432-435.
54. Hauguel T, Bunz F. Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells. Cancer Biol Ther 2003;2:679-684.
55. Lansdorp PM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996;5:685-691.
56. Poon SSS, Martins UM, Ward RK, Lansdorp PM. Telomere length measurement using digital fluorescence microscopy. Cytometry 1999;36:267-278.
57. Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurements by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry 2002;47:89-99.